Breakthroughs In Prostate Cancer Risk Assessment: IsoPSA, a Novel Approach to Improve Biopsy Decision-Making | Sponsored by: IsoPSA
Sunday, May 5, 2024 1:30 PM to 2:15 PM · 45 min. (US/Central)
Product Theater
Information
We invite you to join us for our product theater "Breakthroughs In Prostate Cancer Risk Assessment: IsoPSA, a Novel Approach to Enhance Biopsy Decision-Making." Join us on May 5th from 1:30-2:15 pm, as we discuss
Drawbacks of conventional PSA screening
Current testing to further stratify risk for prostate cancer and their constraints
In-depth look into IsoPSA and the key differentiators and advantages
Review of compelling IsoPSA clinical data and case studies
Interactive Q&A – Have your questions answered by Dr. Berger
Drawbacks of conventional PSA screening
Current testing to further stratify risk for prostate cancer and their constraints
In-depth look into IsoPSA and the key differentiators and advantages
Review of compelling IsoPSA clinical data and case studies
Interactive Q&A – Have your questions answered by Dr. Berger
